Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

February 19, 2015

Newsletter Sponsor

Using USP 735 As An Alternative to USP 232/233 for Elemental Impurity Analysis in Pharmaceutical Products
From Shimadzu
With new USP regulations for elemental impurity analysis becoming enforceable in late 2015, many laboratories are getting prepared to fulfil these requirements. This webinar will discuss one alternative approach to elemental impurity analysis that meets the requirements of sensitivity and repeatability with very little sample preparation.

	Industry News

Genau & More and Norconsult have entered into a partnership agreement.

Media Coverage of Political Disputes about Vaccines and other Public Health Measures Can Do Harm

Exel White Paper Identifies Solutions to Life-Threatening Kinks in Pharmaceutical Supply Chain

Boehringer Ingelheim Renews Global Technology Collaboration Agreement with VTU Technology

	Featured Articles

HORIZON LINES: A Quarterly Review of NDAs HORIZON LINES: A Quarterly Review of NDAs New Drug Application (NDA) approval involves various steps including pre-clinical research, investigational new drug application, clinical studies, and NDA review. NDAs can be obtained for new ... read more »

Supply Chain Guidance and the United States Pharmacopeia Direction Supply Chain Guidance and the United States Pharmacopeia Direction The ongoing health care crisis around drug safety and reliability has the attention of the global regulatory agencies responsible for providing the public with safe health care products. Regulatory ... read more »

	Featured Partners

Benefit from 50 years of CMO knowledge
From Ash Stevens
Benefit from 50 years of CMO knowledge, visit ashstevens.com and contact Ash Stevens today. read more »

	Featured Video

Webinar: The Role of the Monitor: Considerations to Adopting a Risk-Based Monitoring System
Webinar: The Role of the Monitor: Considerations to Adopting a Risk-Based Monitoring System
Marcus Thornton, Senior Director of Medidata Solutions, discusses considerations to adopting a risk-based monitoring system. read more »

	Events


2015 PDA Annual Meeting		Pharma Contract Manufacturing & Procurement Summit 2015

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA